A team of Chinese researchers has discovered a new bat coronavirus, named HKU5-CoV-2, that poses a potential risk of animal-to-human transmission. The virus utilizes the angiotensin-converting enzyme 2 (ACE2) receptor—the same receptor used by the SARS-CoV-2 virus, which caused the global COVID-19 pandemic.
The research was led by renowned virologist Dr. Shi Zhengli from the Wuhan Institute of Virology, known for her extensive work on bat viruses. The study revealed that while the virus can bind to the human ACE2 receptor, its ability to enter human cells is currently less efficient than SARS-CoV-2. However, scientists warn that future mutations could enhance its infectious potential.
Researchers have also identified possible antiviral treatments and monoclonal antibodies that could be effective against this new virus. Despite the lower likelihood of immediate human infection, experts emphasize the importance of continuous monitoring and preventive research to mitigate future outbreaks.
This discovery has already stirred global concern, particularly in financial markets, where vaccine manufacturers have experienced fluctuations in stock prices. The detection of HKU5-CoV-2 underscores the critical need for ongoing vigilance in identifying and controlling emerging infectious diseases.
Source: Web Team, C6N
